Novo Nordisk in bid for Global Blood Therapeutics

Novo Nordisk has approached Global Blood Therapeutics, a U.S. biotechnology company focused on serious blood disorders, to discuss a potential acquisition.

from Mergers and Acquisitions http://ift.tt/2mjrKAo